CD44 and pancreatic neoplasm: We performed a comprehensive bioinformatics analysis to characterize cell–cell communication changes in metastatic liver tissues and screened for ligand-receptor pairs with enhanced interaction between MASLD liver and tumors: hepatocyte macrophage migration inhibitory factor (MIF) and pancreatic cancer cell surface receptor CD44.